What rapid‑acting insulin dose should be given now for a patient who received NPH (neutral protamine Hagedorn) 10 units four hours ago, has high‑dose prednisone/methylprednisolone therapy, an eGFR of 33 mL/min, and a current capillary glucose likely above 200 mg/dL?

Rapid-Acting Insulin Dosing for Steroid-Induced Hyperglycemia

Given that the patient received NPH 10 units 4 hours ago and is on high-dose prednisone/methylprednisolone with an eGFR of 33 mL/min and glucose likely >200 mg/dL, administer 4 units of rapid-acting insulin now as an initial prandial dose, with correction insulin added based on the exact glucose level using a conservative insulin sensitivity factor of 1:50 given the renal impairment.

Clinical Context and Reasoning

The patient is 4 hours into the NPH peak window (NPH peaks at 4-10 hours 1), which creates a complex dosing scenario. However, the high-dose steroid therapy is driving significant hyperglycemia that requires immediate prandial coverage.

Initial Prandial Insulin Approach

For steroid-induced hyperglycemia with glucose >200 mg/dL, the 2025 ADA Standards recommend initiating prandial insulin at 4 units per dose or 10% of the basal insulin dose 2. Since the patient received 10 units of NPH, this translates to 4 units of rapid-acting insulin as the starting prandial dose.

Correction Insulin Component

Add correction insulin based on the actual glucose reading:

• If glucose 200-250 mg/dL: Add 2 units (using 1:50 ISF)
• If glucose 251-300 mg/dL: Add 3 units
• If glucose >300 mg/dL: Add 4 units

The conservative 1:50 insulin sensitivity factor is critical here because the eGFR of 33 mL/min significantly prolongs insulin action and increases hypoglycemia risk 1, 3.

Steroid-Specific Considerations

High-dose prednisone/methylprednisolone causes a characteristic hyperglycemic pattern with peak effects 4-8 hours after morning administration 4. The 2025 ADA guidelines specifically note that NPH should be dosed in the morning for steroid-induced hyperglycemia 2, which aligns with this patient's regimen.

For glucocorticoid-induced hyperglycemia, expert protocols recommend:

• Basal-bolus distribution of 40% basal and 60% prandial 4
• Larger proportions of prandial insulin given with lunch and dinner when steroids are dosed in the morning 4
• NPH at 0.1-0.3 units/kg given with the glucocorticoid 4

Critical Safety Factors

Renal Impairment Impact

With an eGFR of 33 mL/min (Stage 3B CKD), this patient is at high risk for hypoglycemia 3. The 2022 Endocrine Society guidelines specifically identify eGFR <60 mL/min as a high-risk criterion. Renal failure prolongs insulin action and alters pharmacokinetics 1.

Key adjustments for renal impairment:

• Use conservative correction factors (1:50 instead of 1:30-40)
• Monitor glucose more frequently (every 2-3 hours initially)
• Be prepared to reduce subsequent doses by 10-20% if hypoglycemia occurs 2

NPH Overlap Considerations

Since NPH was given 4 hours ago, the patient is entering the peak action window. The 2012 Endocrine Society guidelines note that when adding rapid-acting insulin to existing NPH therapy, correction doses should be given for glucose >150 mg/dL 1. However, given the severe hyperglycemia (likely >200 mg/dL) and high-dose steroid therapy, full prandial dosing is warranted.

Titration Strategy

Increase the prandial dose by 1-2 units or 10-15% with subsequent meals if glucose remains elevated 2. For this patient on high-dose steroids, expect to need:

• Total daily insulin of 0.5-1.0 units/kg 4, 5
• Distribution: 25-40% basal, 60-75% prandial 4, 5

Studies in patients receiving high-dose dexamethasone with chemotherapy showed insulin requirements of 1-1.3 units/kg/day, with 63-77% as prandial insulin 5. Prednisone-induced insulin resistance may require insulin increases of 70% or more 6.

Common Pitfalls to Avoid

1. Underdosing prandial insulin: Steroid-induced hyperglycemia requires aggressive prandial coverage, not just correction doses
2. Ignoring renal function: The eGFR of 33 requires dose conservatism and frequent monitoring
3. Using sliding scale alone: The 2012 Endocrine Society guidelines explicitly state that prolonged use of sliding scale insulin is not recommended 1
4. Forgetting the NPH peak: Monitor closely for hypoglycemia 6-10 hours after the NPH dose

Monitoring Plan

• Check glucose in 2 hours to assess response
• Continue glucose monitoring every 3-4 hours given the renal impairment
• Adjust subsequent doses based on pattern, not individual readings
• Consider adding or increasing morning NPH dose if fasting glucose remains elevated